• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同球后注射方法的疗效与安全性比较。

Comparison of the efficacy and safety of different methods of posterior subtenon injection.

作者信息

Venkatesh Pradeep, Kumar Chandra Shekhar, Abbas Zahir, Garg Satpal

机构信息

Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.

出版信息

Ocul Immunol Inflamm. 2008 Sep-Oct;16(5):217-23. doi: 10.1080/09273940802209153.

DOI:10.1080/09273940802209153
PMID:19065416
Abstract

PURPOSE

To compare the safety and efficacy of different methods of posterior subtenon (PST) injection of corticosteroids in the treatment of cystoid macular edema secondary to intermediate uveitis.

DESIGN

Prospective comparative randomized interventional study.

PARTICIPANTS

A total number of 30 eyes with cystoid macular edema secondary to intermediate uveitis were examined.

METHODS

Patients were randomized into 3 treatment groups of 10 eyes each. Each group received PST injection of triamcinolone acetonide 0.5 mL (20 mg) by one of three methods: cannula method (group 1), Smith and Nozik method (group 2), or orbital floor injection method (group 3). Patients underwent Snellen's and ETDRS visual acuity (VA) testing, clinical evaluation, optical coherence tomography (OCT), and fundus fluorescein angiography (FFA) at baseline and follow-up visits.

OUTCOME MEASURES

Changes in Snellen and ETDRS VA, OCT retinal thickness and assessments of safety were recorded in follow-up visits.

RESULTS

Postintervention patients were followed up at the 1st, 2nd, 6th, and 12th weeks. Statistically significant (p = .00) improvement in VA was present in group1 from 0.25 +/- 0.08 (mean +/- standard deviation) to 0.75 +/- 0.24, in group 2 from 0.29 +/- 0.12 to 0.78 +/- 0.23, and in group 3 from 0.24 +/- 0.10 to 0.72 +/- 0.27. Statistically significant decrease in OCT central macular thickness (43.97% in group 1, 32.46% in group 2, and 29.75% in group 3) was noted at 12 weeks. However, the difference between individual groups at each visit did not reach statistical significance. Steroid-induced rise in intraocular pressure was observed in all the three groups with no statistical difference between individual groups.

CONCLUSIONS

The different methods of PST injection are equally efficacious in terms of improving visual acuity. However, the cannula method achieves the greatest quantitative reduction in macular thickness. As the cannula method is as efficacious as Smith and Nozik method it may be a preferable method to deliver posterior subtenon injection of corticosteroids.

摘要

目的

比较后Tenon囊下(PST)注射皮质类固醇的不同方法治疗中间葡萄膜炎继发黄斑囊样水肿的安全性和有效性。

设计

前瞻性比较随机干预研究。

参与者

共检查了30只中间葡萄膜炎继发黄斑囊样水肿的眼睛。

方法

患者被随机分为3个治疗组,每组10只眼。每组通过以下三种方法之一接受PST注射0.5 mL(20 mg)曲安奈德:套管法(第1组)、Smith和Nozik法(第2组)或眶底注射法(第3组)。患者在基线和随访时接受Snellen视力和ETDRS视力(VA)测试、临床评估、光学相干断层扫描(OCT)和眼底荧光血管造影(FFA)。

观察指标

随访时记录Snellen和ETDRS视力、OCT视网膜厚度的变化以及安全性评估。

结果

干预后患者在第1、2、6和12周进行随访。第1组视力从0.25±0.08(平均值±标准差)显著提高(p = 0.00)至0.75±0.24,第2组从0.29±0.12提高至0.78±0.23,第3组从0.24±0.10提高至0.72±0.27。在12周时,观察到OCT中心黄斑厚度显著降低(第1组为43.97%,第2组为32.46%,第3组为29.75%)。然而,每次随访时各小组之间的差异未达到统计学显著性。在所有三组中均观察到类固醇诱导的眼压升高,各小组之间无统计学差异。

结论

PST注射的不同方法在提高视力方面同样有效。然而,套管法在黄斑厚度的定量减少方面最为显著。由于套管法与Smith和Nozik法同样有效,它可能是进行后Tenon囊下皮质类固醇注射的首选方法。

相似文献

1
Comparison of the efficacy and safety of different methods of posterior subtenon injection.不同球后注射方法的疗效与安全性比较。
Ocul Immunol Inflamm. 2008 Sep-Oct;16(5):217-23. doi: 10.1080/09273940802209153.
2
Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.用后Tenon囊下曲安奈德对视网膜中央静脉阻塞所致的严重黄斑囊样水肿进行早期治疗。
Retina. 2007 Feb;27(2):180-9. doi: 10.1097/01.iae.0000237584.56552.1c.
3
Intravitreal and posterior subtenon triamcinolone acetonide in idiopathic bilateral uveitic macular oedema.玻璃体内及眼球筋膜囊下注射曲安奈德治疗特发性双侧葡萄膜炎性黄斑水肿
Clin Exp Ophthalmol. 2007 Nov;35(8):713-8. doi: 10.1111/j.1442-9071.2007.01578.x.
4
Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.前瞻性研究曲安奈德与贝伐单抗治疗视网膜中央静脉阻塞继发黄斑水肿。
Retina. 2011 May;31(5):838-45. doi: 10.1097/IAE.0b013e3181f4420d.
5
Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.玻璃体内注射与后Tenon囊下注射曲安奈德治疗弥漫性糖尿病性黄斑水肿的比较。
Ophthalmology. 2005 Sep;112(9):1557-63. doi: 10.1016/j.ophtha.2005.03.023.
6
A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion.三种不同眼内治疗方法治疗视网膜分支静脉阻塞所致黄斑水肿的比较。
Curr Eye Res. 2010 Oct;35(10):925-9. doi: 10.3109/02713683.2010.496540.
7
[Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion].[早期玻璃体腔内注射曲安奈德(IVTA)与延迟注射治疗视网膜静脉阻塞所致黄斑水肿的疗效比较]
J Fr Ophtalmol. 2011 Jun;34(6):355-61. doi: 10.1016/j.jfo.2011.04.008. Epub 2011 Jun 8.
8
Prospective optical coherence tomographic evaluation of the efficacy of oral and posterior subtenon corticosteroids in patients with intermediate uveitis.对中度葡萄膜炎患者口服及后Tenon囊下注射皮质类固醇疗效的前瞻性光学相干断层扫描评估
Graefes Arch Clin Exp Ophthalmol. 2007 Jan;245(1):59-67. doi: 10.1007/s00417-006-0378-3. Epub 2006 Aug 2.
9
Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.玻璃体内注射贝伐单抗与玻璃体内和后Tenon 曲安奈德治疗葡萄膜炎性囊样黄斑水肿的疗效和安全性比较。
Retina. 2011 Jan;31(1):111-8. doi: 10.1097/IAE.0b013e3181e378af.
10
Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.后Tenon囊下及玻璃体内注射曲安奈德治疗糖尿病性黄斑水肿
J Diabetes Complications. 2006 Jul-Aug;20(4):246-51. doi: 10.1016/j.jdiacomp.2005.06.015.

引用本文的文献

1
Risk factors for failing sub-Tenon's triamcinolone acetonide for uveitic macular edema.用于葡萄膜炎性黄斑水肿的球后注射曲安奈德治疗失败的危险因素。
J Ophthalmic Inflamm Infect. 2024 Feb 1;14(1):7. doi: 10.1186/s12348-024-00386-1.
2
Bromfenac 0.09% for the Treatment of Macular Edema Secondary to Noninfectious Uveitis.溴芬酸钠 0.09% 治疗非感染性葡萄膜炎继发的黄斑水肿。
Middle East Afr J Ophthalmol. 2021 Sep 25;28(2):98-103. doi: 10.4103/meajo.meajo_134_21. eCollection 2021 Apr-Jun.
3
Intravitreal Dexamethasone Implants for Refractory Macular Edema in Eyes with Noninfectious Uveitis.
玻璃体内注射地塞米松植入物治疗非感染性葡萄膜炎所致难治性黄斑水肿
J Clin Med. 2021 Aug 24;10(17):3762. doi: 10.3390/jcm10173762.
4
Suprachoroidal Injection of Triamcinolone- Review of a Novel Treatment for Macular Edema Caused by Noninfectious Uveitis.曲安奈德脉络膜上腔注射——非感染性葡萄膜炎所致黄斑水肿新疗法综述
US Ophthalmic Rev. 2020 Fall;13(2):76-79. doi: 10.17925/usor.2020.13.2.76. Epub 2020 Dec 23.
5
Intraocular Inflammation Control and Changes in Retinal and Choroidal Architecture in Refractory Non-Infectious Uveitis Patients after Adalimumab Therapy.阿达木单抗治疗后难治性非感染性葡萄膜炎患者的眼内炎症控制及视网膜和脉络膜结构变化
J Clin Med. 2020 Feb 13;9(2):510. doi: 10.3390/jcm9020510.
6
Iatrogenic retinal detachment secondary to inadvertent subretinal injection during posterior sub-Tenon triamcinolone injection.后Tenon囊下注射曲安奈德时因意外视网膜下注射导致的医源性视网膜脱离。
GMS Ophthalmol Cases. 2019 Feb 12;9:Doc05. doi: 10.3205/oc000094. eCollection 2019.
7
Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non-infectious uveitis.用于治疗非感染性葡萄膜炎所致葡萄膜黄斑水肿(UMO)的抗肿瘤坏死因子生物疗法。
Cochrane Database Syst Rev. 2018 Dec 18;12(12):CD012577. doi: 10.1002/14651858.CD012577.pub2.
8
Intravitreal Dexamethasone Implant in the Treatment of Non-Infectious Uveitic Macular Edema.玻璃体内注射地塞米松植入物治疗非感染性葡萄膜炎性黄斑水肿
Med Hypothesis Discov Innov Ophthalmol. 2018 Winter;7(4):169-175.
9
Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial.眼周曲安奈德与玻璃体内曲安奈德和玻璃体内地塞米松植入物治疗葡萄膜炎性黄斑水肿的比较:眼周与玻璃体内皮质类固醇治疗葡萄膜炎性黄斑水肿(POINT)试验。
Ophthalmology. 2019 Feb;126(2):283-295. doi: 10.1016/j.ophtha.2018.08.021. Epub 2018 Sep 27.
10
The efficacy of preoperative posterior subtenon injection of triamcinolone acetonide in noninfectious uveitic patients with secondary glaucoma undergoing trabeculectomy.术前在接受小梁切除术的继发青光眼非感染性葡萄膜炎患者中进行球后注射曲安奈德的疗效。
Clin Ophthalmol. 2017 Nov 21;11:2057-2063. doi: 10.2147/OPTH.S145957. eCollection 2017.